{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:53:41Z","timestamp":1778662421100,"version":"3.51.4"},"reference-count":40,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Department of Veterans Affairs (VA), Health Services Research & Development Service (HSRD), Precision Monitoring to Transform Care (PRISM) Quality Enhancement Research Initiative (QUERI)","award":["QUE 15\u2013280"],"award-info":[{"award-number":["QUE 15\u2013280"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2023,12,12]]},"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Whether obtaining the more intensive goal systolic blood pressure (SBP) of &lt;130\u2009mm Hg, rather than a less intensive SBP goal of &lt;140\u2009mm Hg poststroke\/transient ischaemic attack (TIA) is associated with incremental mortality and recurrent vascular event benefit is largely unexplored using real-world data. Lowering SBP excessively may result in poorer outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a retrospective cohort study of 26\u2009368 Veterans presenting to a Veterans Administration Medical Center (VAMC) with a stroke\/TIA between October 2015 and July 2018. Patients were excluded from the study if they had missing or extreme BP values, receiving dialysis or palliative care, left against medical advice had a cancer diagnosis, were cared for in a VAMC enrolled in a stroke\/TIA quality improvement initiative, died or had a cerebrovascular or cardiovascular event within 90 days after their index stroke\/TIA. The analytical sample included 12\u2009337 patients. Average SBP during 90 days after discharge was assessed in categories (\u2264105\u2009mm Hg, 106\u2013115\u2009mm Hg, 116\u2013130\u2009mm Hg, 131\u2013140\u2009mm Hg and &gt;140\u2009mm Hg). Separate multivariable Cox proportional hazard regressions were used to examine the relationship between average SBP groups and time to: (1) mortality and (2) any recurrent vascular event, from 90 days to up to 365 days after discharge from the index emergency department visit or inpatient admission.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with those with SBP&gt;140\u2009mm Hg, patients with SBP between 116 and 130\u2009mm Hg had a significantly lower risk of recurrent stroke\/TIA (HR 0.77, 95% CI 0.60 to 0.99) but not cardiovascular events. Patients with SBP lower than 105\u2009mm Hg, compared with those with &gt;140\u2009mm Hg demonstrated a statistically significant higher risk of death (HR 2.07, 95% CI 1.43 to 3.00), but no statistical differences were found in other SBP groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Data support a more intensive SBP goal to prevent recurrent cerebrovascular events among stroke\/TIA patients by 90 days poststroke\/TIA compared with less intensive goal. Very low SBPs were associated with increased mortality risk.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/svn-2023-002759","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:59:51Z","timestamp":1704848391000},"page":"519-529","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Real-world analysis of two ischaemic stroke and TIA systolic blood pressure goals on 12-month mortality and recurrent vascular events"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct02769338","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5358-2735","authenticated-orcid":false,"given":"Jason J","family":"Sico","sequence":"first","affiliation":[{"name":"Internal Medicine and Neurology, Yale University School of Medicine, New Haven, Connecticut, USA"},{"name":"Department of Neurology, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[{"name":"Yale School of Public Health, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J","family":"Myers","sequence":"additional","affiliation":[{"name":"VA Health Services Research and Development (HSR&D) Center for Healthcare Informatics and Communication and the HSR&D Stroke Quality Enhancement Research Initiative (QUERI), Indianapolis, Indiana, USA"},{"name":"Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Levine","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Neurology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn M","family":"Bravata","sequence":"additional","affiliation":[{"name":"Health Services Research and Development (HSR&D) Center for Healthcare Informatics and Communication and the HSR&D Stroke Quality Enhancement Research Initiative (QUERI); Richard L. Roudebush VA Medical Center, Indianapolis, Indiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg W","family":"Arling","sequence":"additional","affiliation":[{"name":"Department of Veterans Affairs (VA), Health Services Research and Development (HSR&D) Precision Monitoring to Transform Care (PRISM) Quality Enhancement Research Initiative (QUERI), Indianapolis, Indiana, USA"},{"name":"Department of Nursing, Purdue University, West Lafayette, Indiana, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"2025081709355733000_9.5.519.1","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-019-1517-x","article-title":"The protocol-guided rapid evaluation of veterans experiencing new transient neurological symptoms (PREVENT) quality improvement program: rationale and methods","volume":"19","author":"Bravata","year":"2019","journal-title":"BMC Neurol"},{"key":"2025081709355733000_9.5.519.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1650"},{"key":"2025081709355733000_9.5.519.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284427"},{"key":"2025081709355733000_9.5.519.4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.16755"},{"key":"2025081709355733000_9.5.519.5","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000375"},{"key":"2025081709355733000_9.5.519.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1511939"},{"key":"2025081709355733000_9.5.519.7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.035851"},{"key":"2025081709355733000_9.5.519.8","first-page":"2542","article-title":"Termination of the ESH-CHL-SHOT trial","volume":"38","author":"Liu","year":"2020","journal-title":"J Hypertens (Los Angel)"},{"key":"2025081709355733000_9.5.519.9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2019.2167","article-title":"Effect of Standard vs intensive blood pressure control on the risk of recurrent stroke: A randomized clinical trial and meta-analysis","volume":"76","author":"Kitagawa","year":"2019","journal-title":"JAMA Neurol"},{"key":"2025081709355733000_9.5.519.10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/HYPERTENSIONAHA.116.08485","article-title":"Blood pressure reduction and secondary stroke prevention: A systematic review and Metaregression analysis of randomized clinical trials","volume":"69","author":"Katsanos","year":"2017","journal-title":"Hypertension"},{"key":"2025081709355733000_9.5.519.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i708","article-title":"Different systolic blood pressure targets for people with history of stroke or transient ischaemic attack: PAST-BP (prevention after stroke--blood pressure) randomised controlled trial","volume":"352","author":"Mant","year":"2016","journal-title":"BMJ"},{"key":"2025081709355733000_9.5.519.12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(13)60852-1","article-title":"Blood-pressure targets in patients with recent Lacunar stroke: the Sps3 randomised trial","volume":"382","author":"Group","year":"2013","journal-title":"The Lancet"},{"key":"2025081709355733000_9.5.519.13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10887-w","article-title":"The J-curve association between systolic blood pressure and clinical outcomes in ischemic stroke or TIA: the BOSS study","volume":"7","author":"Xie","year":"2017","journal-title":"Sci Rep"},{"key":"2025081709355733000_9.5.519.14","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001052"},{"key":"2025081709355733000_9.5.519.15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/picr.picr_62_21","article-title":"Introduction to real-world evidence studies","volume":"12","author":"Chodankar","year":"2021","journal-title":"Perspect Clin Res"},{"key":"2025081709355733000_9.5.519.16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6716","article-title":"Processes of care associated with risk of mortality and recurrent stroke among patients with transient ischemic attack and Nonsevere ischemic stroke","volume":"2","author":"Bravata","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2025081709355733000_9.5.519.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2019-000641","article-title":"Modelling care quality for patients after a transient ischaemic attack within the US veterans health administration","volume":"8","author":"Arling","year":"2019","journal-title":"BMJ Open Qual"},{"key":"2025081709355733000_9.5.519.18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003157","article-title":"Development and validation of electronic quality measures to assess care for patients with transient ischemic attack and minor ischemic stroke","volume":"10","author":"Bravata","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025081709355733000_9.5.519.19","doi-asserted-by":"crossref","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the Department of veterans affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"key":"2025081709355733000_9.5.519.20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.15920","article-title":"Assessment of the protocol-guided rapid evaluation of veterans experiencing new transient neurological symptoms (PREVENT) program for improving quality of care for transient ischemic attack: A Nonrandomized cluster trial","volume":"3","author":"Bravata","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025081709355733000_9.5.519.21","first-page":"164","article-title":"When tight blood pressure control is not for everyone: a new model for performance measurement in hypertension","volume":"36","author":"Steinman","year":"2010","journal-title":"Jt Comm J Qual Patient Saf"},{"key":"2025081709355733000_9.5.519.22","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11040511","article-title":"Cerebral Autoregulation in ischemic stroke: from pathophysiology to clinical concepts","volume":"11","author":"Nogueira","year":"2021","journal-title":"Brain Sci"},{"key":"2025081709355733000_9.5.519.23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1161\/HYPERTENSIONAHA.107.092114","article-title":"Hypertension treatment","volume":"50","author":"Sica","year":"2007","journal-title":"Hypertension"},{"key":"2025081709355733000_9.5.519.24","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/Apha\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am College Cardiol"},{"key":"2025081709355733000_9.5.519.25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000446922","article-title":"The J-curve phenomenon in hypertension","volume":"4","author":"Kang","year":"2016","journal-title":"Pulse (Basel)"},{"key":"2025081709355733000_9.5.519.26","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.24.12.1844"},{"key":"2025081709355733000_9.5.519.27","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.114.003666"},{"key":"2025081709355733000_9.5.519.28","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000094424.38761.56"},{"key":"2025081709355733000_9.5.519.29","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000014509.11540.66"},{"key":"2025081709355733000_9.5.519.30","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000659"},{"key":"2025081709355733000_9.5.519.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11911-8"},{"key":"2025081709355733000_9.5.519.32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.14503\/THIJ-15-5067","article-title":"A review of the JNC 8 blood pressure guideline","volume":"42","author":"Hernandez-Vila","year":"2015","journal-title":"Tex Heart Inst J"},{"key":"2025081709355733000_9.5.519.33","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-9-200311040-00007"},{"key":"2025081709355733000_9.5.519.34","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"The Lancet"},{"key":"2025081709355733000_9.5.519.35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.22.2901"},{"key":"2025081709355733000_9.5.519.36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1210"},{"key":"2025081709355733000_9.5.519.37","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O"},{"key":"2025081709355733000_9.5.519.38","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.115.008821"},{"key":"2025081709355733000_9.5.519.39","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.017142"},{"key":"2025081709355733000_9.5.519.40","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2312"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2023-002759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T16:36:05Z","timestamp":1755448565000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2023-002759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,11,5]]},"published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.1136\/svn-2023-002759"],"URL":"https:\/\/doi.org\/10.1136\/svn-2023-002759","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]}}}